Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis

The goal of this study was to elucidate the anti-pruritic and anti-inflammatory efficacy of ruxolitinib cream in experimentally-induced dermatitis. Atopic dermatitis (AD), the most common chronic relapsing inflammatory skin disease, significantly impairs patients’ quality of life, with pruritus bein...

Descripción completa

Detalles Bibliográficos
Autores principales: Scuron, Monika D., Fay, Brittany L., Connell, Andrew J., Peel, Michael T., Smith, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917252/
https://www.ncbi.nlm.nih.gov/pubmed/33658996
http://dx.doi.org/10.3389/fimmu.2020.620098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917252/
https://www.ncbi.nlm.nih.gov/pubmed/33658996
http://dx.doi.org/10.3389/fimmu.2020.620098

Ejemplares similares